BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.26
−0.12%Margins
Gross margin
12.8%
EBITDA margin
-29.3%
EBIT margin
-33.2%
Net margin
-52.6%
FCF margin
-11.7%
-5.0%
Return on equity
-4.6%
Return on assets
-3.2%
Return on invested capital
0.09x
Asset turnover
-$2.4M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026